1 H & 13 C NMR N-(3-(Allylthio)-1-(benzo[d]thiazol-2-ylamino)-1-oxopropan-2-yl)-4-
(1,2,3,4-tetrahydroacridin-9-ylamino)butanamide (10a) (1,2,3,4-tetrahydroacridin-9-ylamino) hexanamide (10b) (6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino) 11. In vitro activities of TAC-SAC, 9(a-f), and TAC-SPRC, 9(g-l), hybrids, towards AChE inhibition, antioxidant activity (DPPH) and anti-Aβ aggregation (from ref.
1 H & 13 C NMR of N-(3-(Allylthio)-1-(benzo[d]thiazol-2-ylamino)-1-oxopropan-2-yl)-4-
19 and 20) Table S1 Fig (1,2,3,4-tetrahydroacridin-9-ylamino) hexanamide (10b) 
